This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n13https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n17http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n16http://
n8http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Alzheon
rdf:type
wikidata:Q4830453 wikidata:Q24229398 owl:Thing dbo:Agent n17:Agent n17:SocialPerson dbo:Organisation dbo:Company schema:Organization wikidata:Q43229
rdfs:label
Alzheon
rdfs:comment
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients with Alzheimer's disease and other neurological and psychiatric disorders.
foaf:name
Alzheon
foaf:homepage
n16:www.alzheon.com
dbp:name
Alzheon
foaf:depiction
n8:Alzheon_logo.png
dbo:location
dbr:United_States dbr:Framingham,_Massachusetts
dcterms:subject
dbc:Biopharmaceutical_companies dbc:Pharmaceutical_companies_established_in_2013 dbc:Pharmaceutical_companies_of_the_United_States dbc:Health_care_companies_based_in_Massachusetts dbc:Companies_based_in_Framingham,_Massachusetts
dbo:wikiPageID
54318778
dbo:wikiPageRevisionID
1108508706
dbo:wikiPageWikiLink
dbr:Framingham,_Massachusetts dbc:Biopharmaceutical_companies dbc:Companies_based_in_Framingham,_Massachusetts dbr:Biopharmaceutical dbr:Homotaurine dbr:Neurology dbr:Pharmaceutical_drug dbr:Alzheimer's_disease dbr:Mental_disorder dbr:United_States dbc:Pharmaceutical_companies_established_in_2013 dbr:Neil_Flanzraich dbc:Health_care_companies_based_in_Massachusetts dbc:Pharmaceutical_companies_of_the_United_States dbr:Pharmaceutical_industry
dbo:wikiPageExternalLink
n16:www.alzheon.com
owl:sameAs
n13:3cUfD wikidata:Q39052964
dbp:wikiPageUsesTemplate
dbt:Infobox_company dbt:Reflist
dbo:thumbnail
n8:Alzheon_logo.png?width=300
dbp:foundation
2013
dbp:homepage
n16:www.alzheon.com
dbp:industry
dbr:Pharmaceutical_industry
dbp:keyPeople
Martin Tolar, MD, PhD Neil Flanzraich
dbp:location
dbr:United_States dbr:Framingham,_Massachusetts
dbp:logo
Alzheon logo.png
dbp:type
Private
dbo:abstract
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients with Alzheimer's disease and other neurological and psychiatric disorders.
prov:wasDerivedFrom
wikipedia-en:Alzheon?oldid=1108508706&ns=0
dbo:wikiPageLength
9362
dbo:foundingYear
2013-01-01
dbo:industry
dbr:Pharmaceutical_industry
dbo:keyPerson
dbr:Neil_Flanzraich
foaf:isPrimaryTopicOf
wikipedia-en:Alzheon